thiazolyl blue has been researched along with Coronary Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feeley, BT; Hoyt, EG; Miniati, DN; Poston, RS; Robbins, RC | 1 |
1 other study(ies) available for thiazolyl blue and Coronary Disease
| Article | Year |
|---|---|
Ex vivo antisense oligonucleotides to proliferating cell nuclear antigen and Cdc2 kinase inhibit graft coronary artery disease.
Topics: Actins; Animals; CDC2 Protein Kinase; Cell Division; Cells, Cultured; Coronary Disease; Disease Models, Animal; Heart Transplantation; Humans; Immunohistochemistry; Macrophages; Male; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Polymerase Chain Reaction; Proliferating Cell Nuclear Antigen; Rats; Rats, Inbred ACI; Rats, Sprague-Dawley; Tetrazolium Salts; Thiazoles; Transcription, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2000 |